Copper deficiency myeloneuropathy: a clue to clioquinol-induced subacute myelo-optic neuropathy?

Neurology. 2008 Aug 26;71(9):622-3. doi: 10.1212/01.wnl.0000324620.86645.c1.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Animals
  • Chelating Agents / adverse effects
  • Clioquinol / adverse effects*
  • Clioquinol / metabolism
  • Copper / deficiency*
  • Copper / metabolism
  • Humans
  • Nerve Fibers, Myelinated / metabolism
  • Nerve Fibers, Myelinated / pathology
  • Optic Nerve / metabolism
  • Optic Nerve / physiopathology
  • Optic Nerve Diseases / chemically induced*
  • Optic Nerve Diseases / metabolism*
  • Optic Nerve Diseases / physiopathology
  • Spinal Cord / metabolism
  • Spinal Cord / physiopathology
  • Spinal Cord Diseases / chemically induced*
  • Spinal Cord Diseases / metabolism*
  • Spinal Cord Diseases / physiopathology
  • Zinc / adverse effects
  • Zinc / metabolism

Substances

  • Chelating Agents
  • Copper
  • Clioquinol
  • Zinc